SeaO2 Nutrition (SeaO2 Algae Pty Ltd)

One of the tiniest organisms on Earth. One of the largest opportunities in Nutrition.

SeaO2 Nutrition (SeaO2 Algae P/L)

Share via:

LinkedIn

Facebook

Email

Microalgae fuelled evolution. We're unleashing its potential now.

SeaO₂'s purpose is to take microalgae from untapped potential to a global nutrition solution. We grow Nannovia™, a marine microalgae naturally rich in omega-3. It's the source fish get their Omega-3 from. However, Nannovia™ arrives as a consumer-ready powder, not an oil: sustainable, scalable, and ready to drop into everyday foods and supplements.

Omega-3 is one of the most important nutrients for cellular health: heart, brain, mood, eyes, immunity. Yet over 80% of people in the developed world don't get enough of it, and the ocean we've relied on to supply it is running short.

We think there's a better way, and it's been at the beginning of the food chain the whole time.

We've already built the facility, earned the certifications, and started selling.

This raise is about scaling the vision: new product formats, new offerings like astaxanthin, and more capacity, so this solution can reach people everywhere.

Want to know more? Watch the Investor Q&A here

$7M facility built, certified, and already generating revenue

Australia's largest food grade microalgae facility; designed, built and operated in-house.
GMP & HACCP certiﬁed, with independent safety and digestibility analysis from the University of Queensland.
$3M in matched funding from the Australian Government's CRC-P grant program (~$1M received to date, and $2M still to come).
Over $500,000 of product sold (retail value) in our first season, plus $150,000+ in contract cultivation revenue.

World leading technology, proprietary (exclusive & royalty-free) strains

SeaO₂ Nutrition have built a uniquely capable facility – perhaps the world’s most advanced for production of phototrophic microalgae (grows using just light and photosynthesis to make it’s own food).
The facility is capable of growing difficult to produce microalgae species, as well as easier ones, with highly consistent nutritional properties and food grade quality.
Our first proprietary product is a Nannochloropsis microalgae distinctively high in Omega-3 EPA; Nannovia™.
- To date, Nannovia™ has been sold wholesale to a small number of supplement brands. All have re-ordered. Retail value of these sales is approx. $500k.
- A further 20+ health brands are currently in discussion.
- We have capacity to produce 75,000kg of Nannovia™ p.a.
SeaO₂ Nutrition will begin retailing Nannovia™ in late 2026, with various blends planned for 2027.
Additional microalgae species are planned for commercial launch in 2027.
SeaO2 Nutrition also offer contract cultivation services, and have been the primary supplier for PhycoHealth since late 2025.

SeaO2 has solved the supplement industry's Omega-3 EPA supply issue

Nannovia™ sits within a small, under-served niche inside a growing category - not a broad, contested market.
- The total microalgae industry is valued at roughly US$15B (2026).
- Algae-derived omega-3 represents only 7–9% of that industry (~US$1.0–1.3B), and within that segment, DHA-dominant products (Schizochytrium, Crypthecodinium) command 2/3 of share.
- Nannovia's EPA-dominant profile addresses the remaining, structurally under-served 1/3 - a genuine white-space, rather than a crowded-market.

Dwindling fish stocks and increasing demand means the annual global gap of EPA and DHA supply has already reached 1.1 million tons (Schade et al. 2020).
Supplement companies need it, they want it, and at SeaO₂ we've made it- in a way that's better for the planet, and healthier for people.

Delivering innovative technology is tough. Milestones matter.

Facility designed, approved - Construction starts (Feb 2023)
Construction Completed (Jul 2024)
Commissioning Completed (Dec 2024)
1st wholesale Nannovia™ sale (May 2025)
Food and Beverage Accelerator grant Awarded (June 2025)
CRC-P Grant Awarded (Aug 2025)
1st Contract Cultivation Sale (Sep 2025)
GMP & HACCP Accreditation Awarded (Dec 2025)
Haematococcus successfully harvested from green-house pond
(Mar 2026)
$3,818,253 additional equity contributed by Co-Founder Peter Philipp (Oct 2026)

- - - - - - - - - - - - - - - - - - - - - - - - - - - -

1st retail Nannovia sale (Nov 2026)
Crowd Sourced Funding secured (Nov 2026)
US Regulatory approval – Self-Affirmed GRAS (Mar 2027)
1st Haematococcus sale (Mar 2027)
1st significant Nannovia sale to US (Oct 2027)

This technology is difficult to replicate

Nannovia™ is a powder, not an oil. Shelf stable, whole cell, and unlike fish oil it drops straight into health foods and supplements. That creates opportunities the incumbents and their oils can't reach.

One facility, multiple products. The plant was designed to run a broad range of algal species across salt and fresh water. We're already producing a proprietary seaweed strain under contract for PhycoHealth, with two more species in scale-up

Shareholder support is appreciated

Shareholders investing will receive all the benefits listed up to their investment amount.

$350: 50% discount on 1^st order of Nannovia™ (10% discount ongoing)
$1,000: Nannovia™ Tote Bag
$3,000: Nannovia™ Drink Bottle
$5,000: Site Tour
$10,000: 12 month supply of Nannovia™
$20,000: Dinner or Lunch with Dr Skye Thomas-Hall

The Team

Peter Philip

Co-Founder / Advisor

Leader in marine construction, responsible for designing and delivering some of the largest and most innovative projects in Australia. Peter advises on engineering and production, as well as commercial strategy.

Gian Minns

Co-Founder / Director

Experienced in technology development and commercial leadership, having held senior roles in both multi-national and start-up organisations. Gian plays an active role as a director of the business.

Dr Skye Thomas-Hall

Co-Founder / CEO

Highly published and cited microalgae researcher, and one of the most experienced commercial cultivators globally. Skye is the operational leader of the company.

Stephen Conti

Production Manager

Experienced agriculture and operations leader, with a background in business management and economics. Stephen seemingly makes things happen effortlessly, ensuring smooth running of the facility.

Experienced in technology development and commercial leadership, having held senior roles in both multi-national and start-up organisations. Gian plays an active role as a director of the business.

Highly published and cited microalgae researcher, and one of the most experienced commercial cultivators globally. Skye is the operational leader of the company.

Experienced agriculture and operations leader, with a background in business management and economics. Stephen seemingly makes things happen effortlessly, ensuring smooth running of the facility.

Jean-Baptiste Rouxel

Cultivation Manager

Master biologist with a passion for health. “JB” does whatever it takes to ensure our microalgae cultures remain in peak condition and offer-up their full potential value when harvested.

Marsanne Chabert

Quality Control Manager

Credentially academic and operationally in Food and Biological Process Engineering, with a drive for customer satisfaction. Marsanne is ensures everything produced at SeaO₂ is without compromise.

Dr Reuben Brown

Process Engineer

a.k.a. Dr. "Control Freak", Reuben leads site automation and real-time sensor analysis, ensuring we always have up-to-the-moment insights into the health of the cultures.